Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 74 results found. Search for [ COVID-19 vaccine china trials phase 3 ]

Results 1 to 21 of 74
BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


Reuters
October 16, 2020
China has said that while reasonable profits for companies are permitted, COVID-19 vaccines should be priced close to cost


PTI
October 16, 2020
A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years


BusinessToday.In
October 10, 2020
China was the first to report the outbreak, identified the pathogen and shared the genome sequence with the world, said Chinese Foreign Ministry spokesperson


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Reuters
September 26, 2020
China launched its emergency programme in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official


Associated Press
September 25, 2020
Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


Rupa Burman Roy
September 16, 2020
Gold, Silver prices today:  On the Multi Commodity Exchange, Gold October Futures gained Rs 166 at Rs 51,935, after hitting an intraday high of Rs 51,943 against the previous close of Rs 51,769 per 10 gm.


BusinessToday.In
September 15, 2020
Forex traders said news related to coronavirus vaccine and sustained foreign fund inflows also aided to gains in the local unit


Rupa Burman Roy
September 15, 2020
Gold, Silver prices today: Commodity analysts said traders are awaiting the outcome from the US central bank's two-day policy meeting, scheduled on September 15-16.


Reuters
September 15, 2020
A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech are developing the three vaccines under the state's emergency use programme


BusinessToday.In
September 15, 2020
India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


Reuters
September 6, 2020
The extent of inoculations under the emergency program, which China launched in July but has released few details about, points to how actively it is using experimental vaccines in the hopes of protecting essential workers against a potential COVID-19 resurgence


Reuters
September 3, 2020
Michael Osterholm, a University of Minnesota infectious disease expert, said he was concerned about an \"October surprise\" with a vaccine being rushed through ahead of the election


Reuters
September 1, 2020
The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for COVID-19


BusinessToday.In
August 29, 2020
Coronavirus vaccine update: 'We are delivering life-saving therapies and (we) will produce a vaccine before the end of this year or maybe even sooner. We will defeat the virus and the pandemic,' US President Donald Trump said


Reuters
August 28, 2020
China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), also said it had obtained emergency use approval for a coronavirus vaccine candidate


PAGES 1 OF 4  1234